Screener
Bicara Therapeutics BCAX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Bicara Therapeutics’s reported figures.
The source filing: Bicara Therapeutics’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033429
FAQ
- What is Bicara Therapeutics's enterprise value?
- Bicara Therapeutics (BCAX) reported enterprise value of $966.81M in Q1 2026.
- How has Bicara Therapeutics's enterprise value changed year-over-year?
- Bicara Therapeutics's enterprise value increased by 288.3% year-over-year, from $248.96M to $966.81M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Bicara Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude